北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心  > 期刊论文
学科主题: 临床医学
题名:
The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries
作者: Sun, Guo-ping; Sun, Yan; Xu, Rui-hua; Xu, Jian-Ming; Li, Jin; Wang, Jin-Wan; Qin, Shukui; Feng, Ji Feng; Ba, Yi; Shen, Lin; Bai, Yu-Xian; Sun, Yihong; Pan, Hongming; Cheng, Ying; Yu, Shiying; Zhong, Haijun; Bai, Li; Luo, Rongcheng; Kobayashi, Mikiro; Ohtsu, Atsushi
刊名: JOURNAL OF CLINICAL ONCOLOGY
发表日期: 2013-05-20
卷: suppl.S, 期:15
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
语种: 英语
WOS记录号: WOS:000335419601482
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/56149
Appears in Collections:北京大学临床肿瘤学院_胃肠肿瘤中心_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
2.Beijing 301 PLA Hosp, Beijing, Peoples R China
3.Guangzhou Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
4.GSK Japan Tokyo Head Off, Tokyo, Japan
5.Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
6.Jilin Prov Canc Hosp, Changchun, Peoples R China
7.Tongji Hosp, Ctr Oncol, Wuhan, Peoples R China
8.An Hui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
9.Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
10.Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
11.Acad Mil Med Sci, Hosp 307, Ctr Canc, Beijing, Peoples R China
12.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
13.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
14.Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China
15.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
16.Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
17.Peking Univ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp, Beijing 100871, Peoples R China
18.Harbin Med Univ, Tumor Hosp, Harbin, Peoples R China
19.Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
20.Shao Yifu Hosp, Hangzhou, Zhejiang, Peoples R China

Recommended Citation:
Sun, Guo-ping,Sun, Yan,Xu, Rui-hua,et al. The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Sun, Guo-ping]'s Articles
[Sun, Yan]'s Articles
[Xu, Rui-hua]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Sun, Guo-ping]‘s Articles
[Sun, Yan]‘s Articles
[Xu, Rui-hua]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace